Universal Ibogaine Inc (TSE:IBO) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Universal Ibogaine Inc. has successfully completed a non-brokered private placement, raising $270,000 through the issuance of 13.5 million common shares at $0.02 each. These funds are earmarked for the advancement of their Health Canada clinical trial application for an ibogaine-based treatment for addiction, as well as for general corporate purposes. Additionally, the company has canceled its previous offer to sell common shares at $0.015 each.
For further insights into TSE:IBO stock, check out TipRanks’ Stock Analysis page.